Chen, J., & Cunha, R. A. (2020). The belated US FDA approval of the adenosine A(2A) receptor antagonist istradefylline for treatment of Parkinson’s disease. Purinergic Signal.
Style de citation ChicagoChen, Jiang-Fan, et Rodrigo A. Cunha. "The Belated US FDA Approval of the Adenosine A(2A) Receptor Antagonist Istradefylline for Treatment of Parkinson’s Disease." Purinergic Signal 2020.
Style de citation MLAChen, Jiang-Fan, et Rodrigo A. Cunha. "The Belated US FDA Approval of the Adenosine A(2A) Receptor Antagonist Istradefylline for Treatment of Parkinson’s Disease." Purinergic Signal 2020.
Attention : ces citations peuvent ne pas être correctes à 100%.